Randall A. Oyer

1.2k total citations
25 papers, 170 citations indexed

About

Randall A. Oyer is a scholar working on Economics and Econometrics, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Randall A. Oyer has authored 25 papers receiving a total of 170 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Economics and Econometrics, 11 papers in Public Health, Environmental and Occupational Health and 10 papers in Oncology. Recurrent topics in Randall A. Oyer's work include Economic and Financial Impacts of Cancer (10 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Ethics in Clinical Research (5 papers). Randall A. Oyer is often cited by papers focused on Economic and Financial Impacts of Cancer (10 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Ethics in Clinical Research (5 papers). Randall A. Oyer collaborates with scholars based in United States and Canada. Randall A. Oyer's co-authors include Lawrence N. Shulman, Ursina Teitelbaum, Neal J. Meropol, Sony Tuteja, Nandi J. Reddy, Kelsey S. Lau‐Min, Lisa Kennedy Sheldon, Ryan Massa, Nevena Damjanov and Mia Levy and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and BMC Cancer.

In The Last Decade

Randall A. Oyer

19 papers receiving 167 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Randall A. Oyer United States 8 77 52 39 39 21 25 170
Amy M. Pick United States 8 49 0.6× 60 1.2× 43 1.1× 22 0.6× 11 0.5× 24 294
Eve M. Segal United States 6 58 0.8× 32 0.6× 32 0.8× 42 1.1× 15 0.7× 13 243
Donna A. Messner United States 11 40 0.5× 69 1.3× 81 2.1× 102 2.6× 6 0.3× 23 327
A. H. Partridge United States 6 115 1.5× 32 0.6× 18 0.5× 10 0.3× 7 0.3× 17 155
Alexander Roediger United Kingdom 8 60 0.8× 15 0.3× 38 1.0× 84 2.2× 6 0.3× 22 203
Élise Martin France 7 59 0.8× 26 0.5× 19 0.5× 11 0.3× 4 0.2× 37 144
Samuel O. Azubuike Nigeria 7 190 2.5× 57 1.1× 18 0.5× 18 0.5× 3 0.1× 13 354
Emanuela Taioli United States 6 51 0.7× 69 1.3× 19 0.5× 8 0.2× 10 0.5× 7 214
Kristen L. Fessele United States 9 140 1.8× 61 1.2× 25 0.6× 54 1.4× 2 0.1× 41 277
Behin Yektashenas United States 4 23 0.3× 23 0.4× 10 0.3× 25 0.6× 8 0.4× 9 260

Countries citing papers authored by Randall A. Oyer

Since Specialization
Citations

This map shows the geographic impact of Randall A. Oyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randall A. Oyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randall A. Oyer more than expected).

Fields of papers citing papers by Randall A. Oyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randall A. Oyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randall A. Oyer. The network helps show where Randall A. Oyer may publish in the future.

Co-authorship network of co-authors of Randall A. Oyer

This figure shows the co-authorship network connecting the top 25 collaborators of Randall A. Oyer. A scholar is included among the top collaborators of Randall A. Oyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randall A. Oyer. Randall A. Oyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tuteja, Sony, Xingmei Wang, Donna Capozzi, et al.. (2025). Implementation of DPYD and UGT1A1 Testing in Patients With GI Cancer: A Prospective, Nonrandomized Clinical Trial. JCO Precision Oncology. 9(9). e2500086–e2500086.
2.
Sedhom, Ramy, Jinbo Chen, Yang Li, et al.. (2024). Behavioral economic interventions to embed early palliative care in community oncology (BE-EPiC): A pragmatic cluster-randomized trial.. Journal of Clinical Oncology. 42(16_suppl). 12075–12075. 1 indexed citations
3.
4.
Lau‐Min, Kelsey S., Jessica M. Long, Danielle McKenna, et al.. (2024). Pilot implementation study of a default genetic referral process for patients with early-onset colorectal cancer. Genetics in Medicine Open. 3. 101902–101902.
5.
Boehmer, Leigh, A. G. Howson, Randall A. Oyer, et al.. (2024). Oncologist-Reported Barriers and Facilitators to Offering Cancer Clinical Trials to Their Patients. Current Oncology. 31(6). 3017–3029. 1 indexed citations
6.
Urbanowicz, Ryan J., et al.. (2023). Toward Predicting 30-Day Readmission Among Oncology Patients: Identifying Timely and Actionable Risk Factors. JCO Clinical Cancer Informatics. 7(7). e2200097–e2200097. 5 indexed citations
7.
Barrett, Nadine J., Leigh Boehmer, Al B. Benson, et al.. (2023). An Assessment of the Feasibility and Utility of an ACCC-ASCO Implicit Bias Training Program to Enhance Racial and Ethnic Diversity in Cancer Clinical Trials. JCO Oncology Practice. 19(4). e570–e580. 16 indexed citations
8.
Bradley, Cathy J., Smita Bhatia, Julie Bynum, et al.. (2022). Policies and Practices to Address Cancer’s Long-Term Adverse Consequences. JNCI Journal of the National Cancer Institute. 114(8). 1065–1071. 5 indexed citations
9.
Lau‐Min, Kelsey S., Maria N. Nelson, Nandi J. Reddy, et al.. (2022). Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation. BMC Cancer. 22(1). 47–47. 22 indexed citations
10.
Boehmer, Leigh, Brianna Hoffner, Yurii B. Shvetsov, et al.. (2022). Role of Oncology Advanced Practitioners to Enhance Clinical Research. Journal of the Advanced Practitioner in Oncology. 13(2). 107–119. 11 indexed citations
11.
Harr, Margaret, Håkon Håkonarson, Jessica P. Marini, et al.. (2022). Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guide Chemotherapy Dosing. Frontiers in Oncology. 12. 859846–859846. 10 indexed citations
12.
Parikh, Ravi B., Cathy J. Bradley, Deborah Estrin, et al.. (2022). Digital Health Applications in Oncology: An Opportunity to Seize. JNCI Journal of the National Cancer Institute. 114(10). 1338–1339. 33 indexed citations
13.
Pressman, Alice, Patricia A. Hurley, Suanna S. Bruinooge, et al.. (2022). Availability of data for screening, offering, and consenting patients to cancer clinical trials: Report from an ASCO-ACCC collaboration.. Journal of Clinical Oncology. 40(16_suppl). 6530–6530.
14.
Dale, William, Kah Poh Loh, Efrat Dotan, et al.. (2021). Use of the Delphi method to develop a guideline-based geriatric oncology gap assessment.. Journal of Clinical Oncology. 39(28_suppl). 236–236. 1 indexed citations
15.
Smeltzer, Matthew, Leigh Boehmer, Nicholas R. Faris, et al.. (2021). An Optimal Care Coordination Model for Medicaid Patients with Lung Cancer: Results from Beta Model Testing. Oncology Issues. 36(3). 80–94.
16.
Oyer, Randall A., et al.. (2021). An Optimal Care Coordination Model for Medicaid Patients with Lung Cancer: Rationale, Development, and Design. Oncology Issues. 36(2). 30–35. 2 indexed citations
17.
Lau‐Min, Kelsey S., Nevena Damjanov, Ryan Massa, et al.. (2020). DPYD and UGT1A1 Pharmacogenetic Testing in Patients with Gastrointestinal Malignancies: An Overview of the Evidence and Considerations for Clinical Implementation. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 40(11). 1108–1129. 19 indexed citations
18.
Boehmer, Leigh, Brianna Hoffner, Jessica Rhee, et al.. (2020). Role of oncology-advanced practitioners to enhance clinical research.. Journal of Clinical Oncology. 38(29_suppl). 95–95.
19.
Sivendran, Shanthi, et al.. (2019). Anticancer Therapy at the End of Life: Lessons From a Community Cancer Institute. Journal of Palliative Care. 36(2). 87–92. 1 indexed citations
20.
Takvorian, Samuel U, Erin P. Balogh, Sharyl J. Nass, et al.. (2019). Developing and Sustaining an Effective and Resilient Oncology Careforce: Opportunities for Action. JNCI Journal of the National Cancer Institute. 112(7). 663–670. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amy M. Pick Breakdown of academic impact, for papers by Eve M. Segal Breakdown of academic impact, for papers by Donna A. Messner Breakdown of academic impact, for papers by A. H. Partridge Breakdown of academic impact, for papers by Alexander Roediger Breakdown of academic impact, for papers by Élise Martin Breakdown of academic impact, for papers by Samuel O. Azubuike Breakdown of academic impact, for papers by Emanuela Taioli Breakdown of academic impact, for papers by Kristen L. Fessele Breakdown of academic impact, for papers by Behin Yektashenas
Rankless by CCL
2026